Jiří Polívka

4.0k total citations · 2 hit papers
53 papers, 1.9k citations indexed

About

Jiří Polívka is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jiří Polívka has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Jiří Polívka's work include Glioma Diagnosis and Treatment (11 papers), Cancer Genomics and Diagnostics (8 papers) and Acute Ischemic Stroke Management (7 papers). Jiří Polívka is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Cancer Genomics and Diagnostics (8 papers) and Acute Ischemic Stroke Management (7 papers). Jiří Polívka collaborates with scholars based in Czechia, Germany and United States. Jiří Polívka's co-authors include Filip Jankú, Olga Golubnitschaja, Ondřej Topolčan, Martin Pešta, Vladimír Rohan, L Holubec, Pavol Žúbor, Katarzyna Konieczka, Jiří Ferda and Rostyslav Bubnov and has published in prestigious journals such as Stroke, Annals of Oncology and Pharmacology & Therapeutics.

In The Last Decade

Jiří Polívka

49 papers receiving 1.8k citations

Hit Papers

Molecular targets for cancer therapy in the PI3K/AKT/mTOR... 2013 2026 2017 2021 2013 2023 200 400 600

Peers

Jiří Polívka
Ali S. Alzahrani Saudi Arabia
Jun Cai China
Mi Jung Kwon South Korea
Hui Huang China
Jiří Polívka
Citations per year, relative to Jiří Polívka Jiří Polívka (= 1×) peers Nikolaos Kavantzas

Countries citing papers authored by Jiří Polívka

Since Specialization
Citations

This map shows the geographic impact of Jiří Polívka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Polívka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Polívka more than expected).

Fields of papers citing papers by Jiří Polívka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Polívka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Polívka. The network helps show where Jiří Polívka may publish in the future.

Co-authorship network of co-authors of Jiří Polívka

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Polívka. A scholar is included among the top collaborators of Jiří Polívka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Polívka. Jiří Polívka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pešta, Martin, Vlastimil Kulda, Pavel Ostašov, et al.. (2024). Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC). In Vivo. 38(4). 1799–1805. 1 indexed citations
2.
Polívka, Jiří, et al.. (2023). Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma. Anticancer Research. 43(2). 695–706. 5 indexed citations
3.
Kropp, Martina, Olga Golubnitschaja, Alena Mazuráková, et al.. (2023). Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation. The EPMA Journal. 14(1). 21–42. 192 indexed citations breakdown →
4.
Pešta, Martin, et al.. (2022). Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer. Diagnostics. 12(8). 1799–1799. 16 indexed citations
5.
Golubnitschaja, Olga, Jiří Polívka, Martin Pešta, et al.. (2022). Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach. The EPMA Journal. 13(4). 535–545. 36 indexed citations
6.
Gouda, Mohamed A., Jiří Polívka, Hong Huang, et al.. (2021). Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma. ESMO Open. 7(1). 100357–100357. 17 indexed citations
7.
Pešta, Martin, Radek Kučera, Ondřej Topolčan, et al.. (2019). Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients. Cancers. 11(6). 864–864. 33 indexed citations
8.
Polívka, Jiří & Vladimír Rohan. (2018). Predictive and individualized management of stroke—success story in Czech Republic. The EPMA Journal. 9(4). 393–401. 4 indexed citations
9.
Polívka, Jiří, et al.. (2018). Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine. The EPMA Journal. 9(1). 1–13. 37 indexed citations
10.
Polívka, Jiří, et al.. (2017). Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. Anticancer Research. 37(1). 21–33. 102 indexed citations
11.
Smokovski, Ivica, Jiří Polívka, Pavol Žúbor, et al.. (2017). Postmenopausal breast cancer: European challenge and innovative concepts. The EPMA Journal. 8(2). 159–169. 22 indexed citations
12.
Žúbor, Pavol, et al.. (2017). Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach?. The EPMA Journal. 8(2). 129–140. 37 indexed citations
13.
Polívka, Jiří, et al.. (2016). Current status of biomarker research in neurology. The EPMA Journal. 7(1). 14–14. 29 indexed citations
14.
15.
Polívka, Jiří, Martin Pešta, & Filip Jankú. (2015). Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?. Expert Review of Molecular Diagnostics. 15(12). 1631–1644. 43 indexed citations
16.
Polívka, Jiří, et al.. (2014). Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia. BioMed Research International. 2014. 1–5. 28 indexed citations
18.
Polívka, Jiří, et al.. (2014). Pre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendations. The EPMA Journal. 5(1). 22–22. 4 indexed citations
19.
Rektor, Ivan, et al.. (2009). High Doses of Rotigotine Transdermal Patch. Clinical Neuropharmacology. 32(4). 193–198. 6 indexed citations
20.
Babić, Tomislav, et al.. (2006). Rotigotine Transdermal Patch Enables Rapid Titration to Effective Doses in Advanced-Stage Idiopathic Parkinson Disease. Clinical Neuropharmacology. 29(4). 238–242. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026